The current valuation score of Absci Corp is 5.92, ranking 354 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.44, which is -89.50% below the recent high of -0.99 and -49.36% above the recent low of -14.10.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.